FDA Approves New Drug for Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma 0 24.01.2023 01:23 «La Crosse Tribune» (lacrossetribune.com) MONDAY, Jan. 23, 2023 (HealthDay News) -- The U.S. Food and Drug Administration has approved zanubrutinib (Brukinsa), a next-generation BTK inhibitor, for the treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
